Latest Press Release

18-Mar-25

Convatec showcases its strongest wound care innovation pipeline ever at EWMA

26-Feb-25

Annual results for the year ended 31 December 2024

26-Jan-25

Convatec welcomes the postponement of Local Coverage Determinations (LCDs) on skin substitutes in the United States

16-Dec-24

Convatec unveils new resources to support intermittent catheter users to live life confidently

14-Nov-24

Convatec responds to Local Coverage Determinations (LCDs) on skin substitutes in the United States

12-Nov-24

Trading update for the ten months ended 31 October 2024

21-Oct-24

Convatec collaborates with AbbVie for VYALEV™ therapy for the treatment of advanced Parkinson’s disease in the United States

10-Oct-24

Convatec update on InnovaMatrix® AC clinical data – second randomised controlled trial authorised